Listed

John Wiley & Sons, Inc.: Form 10-Q for the period ended Jan 31, 2025

Filed with the SEC on Mar 7, 2025 and accepted by EDGAR at Mar 7, 2025, 11:50 ET.

Share

Management's discussion and analysis

As filed, 65,416 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The information in our Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) should be read together with our Condensed Consolidated Financial Statements and related notes set forth in Item 1 of Part I of this Quarterly Report on Form 10-Q, our MD&A set forth in Item 7 of Part II of our 2024 Form 10-K and our Consolidated Financial Statements and related notes set forth in Item 8 of Part II of our 2024 Form 10-K. See Part II, Item 1A, “Risk Factors,” below and “Cautionary Notice Regarding Forward-Looking Statements “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995,” above, and the information referenced therein, for a description of risks that we face and important factors that we believe could cause actual results to differ materially from those in our forward-looking statements. All amounts and percentages are approximate due to rounding and all dollars are in thousands, except per share amounts or where otherwise noted. When we cross-reference to a “Note,” we are referring to our “Notes to Unaudited Condensed Consolidated Financial Statements,” unless the context indicates otherwise.

OVERVIEW

Wiley is one of the world’s largest publishers and a global leader in research and learning. The Company’s content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. Wiley empowers knowledge seekers to transform today’s biggest obstacles into tomorrow’s brightest opportunities. For more than two centuries, the Company has been delivering on its timeless mission to unlock human potential. Wiley is a predominantly digital company with over 83% of its revenue for the year ended April 30, 2024 generated by digital products and services excluding the Held for Sale or Sold segment revenue. For the year ended April 30, 2024, 48% of revenue excluding the Held for Sale or Sold segment revenue is recurring which includes revenue that is contractually obligated or set to recur with a high degree of certainty.

On June 1, 2023, Wiley’s Board of Directors approved a plan to divest certain businesses that we determined are non-core businesses. Those businesses are University Services, Wiley Edge, and CrossKnowledge. On January 1, 2024 we completed the sale of University Services. On May 31, 2024 we completed the sale of Wiley Edge with the exception of its India operations which sold on August 31, 2024. On August 31, 2024 we completed the sale of CrossKnowledge.

We report financial information for the following segments, as well as a Corporate category, which includes certain costs that are not allocated to the reportable segments:

  • Research includes the reporting lines of Research Publishing and Research Solutions;
  • Learning includes the Academic and Professional reporting lines and consists of publishing and related knowledge solutions;
  • Held for Sale or Sold includes businesses sold in fiscal year 2025 which includes CrossKnowledge and Wiley Edge and in fiscal year 2024 which includes University Services and Tuition Manager.

Through the Research segment, we provide peer-reviewed scientific, technical, and medical (STM) publishing, content platforms, and related services to academic, corporate, and government customers, academic societies, and individual researchers. The Learning segment provides scientific, professional, and education print and digital books, digital courseware to libraries, corporations, students, professionals, and researchers, as well as assessment services to businesses and professionals.

Wiley’s business strategies are tightly aligned with healthy solid growth trends, including ever-increasing global research and development (R&D) spend leading to consistent growth in scientific research output, the transition to open research, and the increasing application of new knowledge into solutions to solve real world problems. These strategies include driving publishing output to meet the global demand for peer-reviewed research and expanding platform and service offerings for corporations and societies. Learning strategies include selectively scaling high-value digital content, courseware, and assessments where the Company sees opportunity. We continue to implement strategies to efficiently and effectively manage print revenue declines while driving growth in our digital lines of business.

RESULTS OF OPERATIONS – THREE MONTHS ENDED JANUARY 31, 2025

THIRD QUARTER SUMMARY

  • US GAAP Results: Consolidated Revenue of $404.6 million (-12%, compared with the prior year), decrease due to the divested businesses, Operating Income of $51.8 million ($+98.2 million, compared with the prior year operating loss), and Diluted Loss per Share of $(0.43) (+$1.65 per share, compared with the prior year diluted loss per share).
  • Adjusted Results at Constant Currency (excluding Held for Sale or Sold segment results): Adjusted Revenue of $404.6 million (+1%, compared with the prior year), Adjusted Operating Income of $57.4 million (+27%, compared with the prior year), Adjusted EBITDA of $93.9 million (+4%, compared with the prior year), and Adjusted EPS of $0.84 (+39%, compared with the prior year).

CONSOLIDATED RESULTS OF OPERATIONS

Revenue:

Revenue for the three months ended January 31, 2025, decreased $56.1 million, or 12%, as compared with the prior year. On a constant currency basis, revenue decreased 12% as compared with the prior year.

Excluding the revenues from the Held for Sale or Sold segment, Adjusted Revenue increased 1% on a constant currency basis.

On a constant currency basis excluding the $9 million content rights project for training GenAI large language models, Adjusted Revenue for the three months ended January 31, 2025 decreased 1% as compared with the prior year.

Adjusted Revenue

Below is a reconciliation of our consolidated US GAAP Revenue, net to Non-GAAP Adjusted Revenue, net:

Three Months Ended January 31, 2025 2024
US GAAP Revenue, net $404,626 $460,705
Less: Held for Sale or Sold segment (1) — (58,172)
Non-GAAP Adjusted Revenue, net $404,626 $402,533

(1) Our Adjusted Revenue, net excludes the impact of our Held for Sale or Sold segment revenue.

See the “Segment Operating Results” below for additional details on each segment’s revenue and Adjusted EBITDA performance.

Cost of Sales:

Cost of sales for the three months ended January 31, 2025 of $104.2 million decreased $39.4 million, or 27%, as compared with the prior year. On a constant currency basis, cost of sales decreased 27% as compared with the prior year. This was primarily due to the prior year including employee and marketing costs related to the University Services business which was sold on January 1, 2024 and, to a lesser extent, lower employee costs related to the Wiley Edge business which was sold on May 31, 2024.

Excluding the cost of sales from the Held for Sale or Sold segment, cost of sales decreased 4% as compared with the prior year on a constant currency basis primarily due to lower royalty costs and, to a lesser extent, lower product development and print product costs.

Operating and Administrative Expenses:

Operating and administrative expenses for the three months ended January 31, 2025 of $230.0 million decreased $23.4 million, or 9% as compared with the prior year. On a constant currency basis, operating and administrative expenses decreased 9% as compared with the prior year primarily due to lower employee related costs and, to a lesser extent, lower depreciation, and technology related costs, partially offset by higher professional fees.

Excluding operating and administrative expenses from the Held for Sale or Sold segment, operating and administrative expenses decreased 1% as compared with the prior year on a constant currency basis primarily due to lower depreciation and, to a lesser extent, technology related costs, partially offset by higher professional fees.

Impairment of Goodwill:

We recorded an impairment of goodwill in the three months ended January 31, 2024 of $81.7 million. This charge is reflected in the Impairment of goodwill in the Unaudited Condensed Consolidated Statements of Net (Loss) Income.

As a result of signing a stock and asset purchase agreement to sell Wiley Edge (Edge Agreement) with Inspirit Vulcan Bidco Limited, a private limited company incorporated in England & Wales, and the decrease in the fair value of the business, we tested the goodwill of the Wiley Edge reporting unit within the Held for Sale or Sold segment for impairment. We concluded that the carrying value of the Wiley Edge reporting unit was above its fair value which resulted in a pretax noncash goodwill impairment of $81.7 million in the three months ended January 31, 2024. Such impairment reduced the goodwill of the Wiley Edge reporting unit to zero.

Restructuring and Related Charges:

We recorded restructuring and related charges in the three months ended January 31, 2025 and 2024 of $5.6 million and $14.8 million, respectively. These charges are reflected in Restructuring and related charges on our Unaudited Condensed Consolidated Statements of Net (Loss) Income.

Global Restructuring Program

Beginning in fiscal year 2023, the Company initiated the Global Restructuring Program which was expanded in fiscal year 2024 to include those actions that will focus Wiley on its leading global position in the development and application of new knowledge and drive greater profitability, growth, and cash flow. We will focus on our strongest and most profitable businesses and large market opportunities in Research and Learning, as well as streamline our organization and rightsize our cost structure to reflect these portfolio actions. Under this program, we reduced our real estate square footage occupancy by approximately 35%.

Excluding actions related to the Held for Sale or Sold segment, we anticipate to yield annualized cost savings of approximately $90 million, with approximately $80 million of that to be realized this fiscal year from actions taken starting in fiscal year 2024.

For the three months ended January 31, 2025 and 2024, we recorded pretax restructuring charges of $5.6 million and $14.4 million, respectively, related to this program.

With the completion of our divestitures, we are now focused on optimizing our cost structure, with particular emphasis on aligning our technology costs and other corporate expenses. As a result of these initiatives, we expect to incur additional restructuring charges in future periods, as well ongoing facility-related costs associated with certain properties.

See Note 9, “Restructuring and Related Charges” for more details on the Global Restructuring Program charges.

Business Optimization Program

For the three months ended January 31, 2025 and 2024, we recorded pretax restructuring credits of less than $(0.1) million and charges of $0.4 million, respectively, related to this program.

See Note 9, “Restructuring and Related Charges” for more details on the Business Optimization Program credits and charges.

For the impact of our restructuring programs on diluted loss per share, see the section below, “Diluted Loss per Share.”

Amortization of Intangible Assets:

Amortization of intangible assets was $13.0 million for the three months ended January 31, 2025, a decrease of $0.5 million, or 4%, as compared with the prior year. On a constant currency basis, amortization of intangible assets decreased 3% as compared with the prior year primarily due to the completion of amortization of certain acquired intangible assets.

Operating Income, Adjusted Operating Income (OI) and Adjusted EBITDA:

Operating income was $51.8 million for the three months ended January 31, 2025, compared with the prior year operating loss of $46.4 million. The increase was primarily due to the $81.7 million impairment of goodwill in the prior year, lower costs of sales, and operating and administrative expenses, partially offset by a decrease in revenue.

Adjusted OI on a constant currency basis increased 27% as compared with the prior year. The increase in Adjusted OI was primarily due to an increase in Adjusted Revenue and, to a lesser extent, lower cost of sales and operating and administrative expenses.

Adjusted EBITDA on a constant currency basis increased 4% as compared with the prior year primarily due to an increase in Adjusted Revenue and, to a lesser extent, lower cost of sales, partially offset by higher operating and administrative expenses.

Adjusted OI

Below is a reconciliation of our consolidated US GAAP Operating Income (Loss) to Non-GAAP Adjusted OI:

Three Months Ended January 31, 2025 2024
US GAAP Operating Income (Loss) $51,831 $(46,411)
Adjustments:
Restructuring and related charges 5,574 14,808
Impairment of goodwill — 81,754
Held for Sale or Sold segment Adjusted Operating Income (1) — (4,118)
Non-GAAP Adjusted OI $57,405 $46,033

(1) Our Adjusted OI excludes the impact of our Held for Sale or Sold segment Adjusted Operating Income.

Adjusted EBITDA

Below is a reconciliation of our consolidated US GAAP Net Loss to Non-GAAP EBITDA and Adjusted EBITDA:

Three Months Ended January 31, 2025 2024
Net Loss $(22,954) $(113,875)
Interest expense 14,027 13,321
Provision for income taxes 41,627 1,579
Depreciation and amortization 36,474 45,474
Non-GAAP EBITDA 69,174 (53,501)
Impairment of goodwill — 81,754
Restructuring and related charges 5,574 14,808
Net foreign exchange transaction losses (gains) 4,222 (488)
Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale 15,930 52,404
Other (income) expense, net (1,021) 648
Held for Sale or Sold segment Adjusted EBITDA (1) — (4,118)
Non-GAAP Adjusted EBITDA $93,879 $91,507

(1) Our Non-GAAP Adjusted EBITDA excludes the Held for Sale or Sold segment Non-GAAP Adjusted EBITDA.

Interest Expense:

Interest expense for the three months ended January 31, 2025, was $14.0 million compared with the prior year of $13.3 million. This increase was primarily due to a higher weighted average effective interest rate.

Net Foreign Exchange Transaction (Losses) Gains:

Net foreign exchange transaction losses of $(4.2) million for the three months ended January 31, 2025 were primarily due to losses on our foreign currency denominated intercompany accounts receivable and payable balances, partially offset by gains on our foreign currency denominated third party accounts receivable and payable balances due to the impact of the change in average foreign exchange rates as compared to the US dollar.

Net foreign exchange transaction gains of $0.5 million for the three months ended January 31, 2024 were primarily due to gains on our foreign currency denominated intercompany accounts receivable and payable balances, partially offset by losses on our third-party receivable and payable balances due to the impact of the change in average foreign exchange rates as compared to the US dollar.

Net Loss on Sale of Businesses, Assets, and Impairment Charges Related to Assets Held-For-Sale:

For the three months ended January 31, 2025 and 2024, we recorded net pretax loss on sale of businesses, assets and impairment charges related to assets held-for-sale as follows:

Three Months Ended January 31, 2025 2024
CrossKnowledge $275 $(5,782)
Wiley Edge (15,566) (20,676)
University Services (639) (25,946)
Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale $(15,930) $(52,404)

These charges are reflected in Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale on our Unaudited Condensed Consolidated Statements of Net (Loss) Income.

On August 31, 2024, we completed the sale of CrossKnowledge which was included in our Held for Sale or Sold segment. The pretax loss on sale was $51.2 million. In connection with the held-for-sale classification, we recognized cumulative impairment charges of $51.0 million which included $55.4 million recognized in fiscal year 2024 and a reduction of $4.4 million in the first quarter of fiscal year 2025. Upon the completion of the sale, we recognized a net gain of $4.2 million in the nine months ended January 31, 2025 due to subsequent changes in the fair value less costs to sell, as well as changes in the carrying amount of the disposal group. We recognized a net gain of $0.3 million in the three months ended January 31, 2025 due to subsequent changes in the carrying amount of the disposal group.

On May 31, 2024, we completed the sale of Wiley Edge which was included in our Held for Sale or Sold segment, with the exception of its India operations which sold on August 31, 2024. The total pretax loss on sale was $34.2 million. In connection with the held-for-sale classification, we recognized cumulative impairment charges of $19.4 million. Upon the completion of the sale, we recognized a net loss of $14.8 million in the nine months ended January 31, 2025 primarily due to subsequent changes in the fair value less costs to sell, partially offset by the sale of the India operations. We recognized a net loss of $15.6 million in the three months ended January 31, 2025 due to subsequent changes in the fair value less costs to sell. In the three months ended January 31, 2025, we reduced the fair value of the Wiley Edge Earnout from $15.0 million at the time of sale to zero. See Note 3, "Divestitures" for further details.

On January 1, 2024, we completed the sale of University Services, which was included in our Held for Sale or Sold segment. The pretax loss on sale was $106.2 million which was reduced by $0.9 million during the nine months ended January 31, 2025 due to third-party customer consents, and working capital adjustments, partially offset by subsequent changes in the costs to sell. We recognized a loss of $0.6 million in the three months ended January 31, 2025 due to subsequent changes in the costs to sell.

In the three months ended January 31, 2024, we recorded a held-for-sale pretax impairment of $26.4 million which includes $20.6 million for Wiley Edge and $5.8 million for CrossKnowledge. The initial pretax loss on the sale of University Services was $101.4 million. Prior to the disposition, we had recorded a held-for-sale impairment of $75.4 million which resulted in an additional loss of $26.0 million in the three months ended January 31, 2024.

See Note 3, “Divestitures” for more details on the divestitures.

Provision for Income Taxes:

Below is a reconciliation of our US GAAP Income (Loss) Before Taxes to Non-GAAP Adjusted Income Before Taxes:

Three Months Ended January 31, 2025 2024
US GAAP Income (Loss) Before Taxes $18,673 $(112,296)
Pretax Impact of Adjustments:
Impairment of goodwill — 81,754
Restructuring and related charges 5,574 14,808
Foreign exchange losses (gains) on intercompany transactions, including the write off of certain cumulative translation adjustments 5,239 (2,128)
Amortization of acquired intangible assets 13,042 13,580
Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale 15,930 52,404
Held for Sale or Sold segment Adjusted Income Before Taxes (1) — (4,120)
Non-GAAP Adjusted Income Before Taxes $58,458 $44,002

(1) Our Adjusted Income Before Taxes excludes the Adjusted Income Before Taxes of our Held for Sale or Sold segment.

Below is a reconciliation of our US GAAP Income Tax Provision to Non-GAAP Adjusted Income Tax Provision, including our US GAAP Effective Tax Rate and our Non-GAAP Adjusted Effective Tax Rate:

Three Months Ended January 31, 2025 2024
US GAAP Income Tax Provision $41,627 $1,579
Income Tax Impact of Adjustments(1):
Restructuring and related charges 404 3,985
Foreign exchange losses (gains) on intercompany transactions, including the write off of certain cumulative translation adjustments 260 (742)
Amortization of acquired intangible assets 1,910 1,152
Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale 154 6,508
Held for Sale or Sold segment Adjusted Tax Provision(2) — (1,252)
Income Tax Adjustments
Impact of valuation allowance on the US GAAP effective tax rate(3) (31,744) —
Non-GAAP Adjusted Income Tax Provision $12,611 $11,230
US GAAP Effective Tax Rate 222.9% (1.4)%
Non-GAAP Adjusted Effective Tax Rate 21.6% 25.5%

(1) For the three months ended January 31, 2025 and 2024, substantially all of the tax impact was from deferred taxes.

(2) Our Adjusted Income Tax Provision excludes the Adjusted Tax Provision of our Held for Sale or Sold segment.

(3) In the three months ended January 31, 2025, there was a $31.7 million impact on the US GAAP effective tax rate due to the valuation allowance on deferred tax assets in the US.

43

The US GAAP effective tax rate for the three months ended January 31, 2025, was 222.9% compared to (1.4)% for the three months ended January 31, 2024. The US GAAP effective tax rate for the three months ended January 31, 2025 was greater than the US GAAP effective tax rate for the three months ended January 31, 2024 primarily driven by US ordinary losses for which no tax benefit can be recognized as a result of the valuation allowance recorded against the net deferred tax assets.

The Non-GAAP Adjusted Effective Tax Rate was 21.6% for the three months ended January 31, 2025 compared to 25.5% for the three months ended January 31, 2024. The decrease in the Non-GAAP Adjusted Effective Tax Rate for the three months ended January 31, 2025 compared with the three months ended January 31, 2024 was primarily due to the mix of income and the impact of a discrete item related to the release of a tax reserve.

Diluted Loss per Share:

Diluted loss per share for the three months ended January 31, 2025 was $(0.43) per share compared with a loss per share of $(2.08) per share for the three months ended January 31, 2024. This increase was primarily due to operating income for the three months ended January 31, 2025 compared to an operating loss in the prior year, a decrease in the net loss on sale of businesses, and impairment charges related to assets held-for-sale, partially offset by an increase in the income tax provision in the three months ended January 31, 2025 compared to the three months ended January 31, 2024.

Below is a reconciliation of our US GAAP Loss per Share to Non-GAAP Adjusted EPS. The amount of the pretax, and the related income tax impact for the adjustments included in the table below are presented in the section above, “Provision for Income Taxes.”

Three Months Ended January 31, 2025 2024
US GAAP Loss Per Share $(0.43) $(2.08)
Adjustments:
Impairment of goodwill — 1.48
Restructuring and related charges 0.09 0.20
Foreign exchange losses (gains) on intercompany transactions, including the write off of certain cumulative translation adjustments 0.09 (0.03)
Amortization of acquired intangible assets 0.20 0.22
Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale 0.29 0.83
Held for Sale or Sold segment Adjusted Net Income(1) — (0.05)
Income tax adjustments 0.58 —
EPS impact of using weighted-average dilutive shares for adjusted EPS calculation (2) 0.02 0.02
Non-GAAP Adjusted EPS $0.84 $0.59

(1) Our Adjusted EPS excludes the Adjusted Net Income of our Held for Sale or Sold segment.

(2) Represents the impact of using diluted weighted-average number of common shares outstanding (54.6 million and 55.3 million shares for the three months ended January 31, 2025 and 2024, respectively) included in the Non-GAAP Adjusted EPS calculation in order to apply the dilutive impact on adjusted net income due to the effect of unvested restricted stock units and other stock awards. This impact occurs when a US GAAP net loss is reported and the effect of using dilutive shares is antidilutive.

On a constant currency basis, Adjusted EPS increased 39% primarily due to an increase in Adjusted Operating Income and, to a lesser extent, a lower Adjusted Effective Tax Rate, and an increase in interest income.

SEGMENT OPERATING RESULTS

RESEARCH Revenue: Three Months Ended January 31, 2025 2024 % Change Favorable (Unfavorable) Constant Currency % Change Favorable (Unfavorable)
Research Publishing $225,874 $216,586 4% 5%
Research Solutions 41,670 39,613 5% 6%
Total Research Revenue 267,544 256,199 4% 5%
Cost of Sales 69,157 69,906 1% 1%
Operating Expenses 122,001 117,961 (3)% (4)%
Amortization of Intangible Assets 10,717 11,234 5% 4%
Adjusted Operating Income 65,669 57,098 15% 17%
Depreciation and amortization 21,918 22,029 1% 0%
Adjusted EBITDA $87,587 $79,127 11% 12%
Adjusted EBITDA Margin 32.7% 30.9%

Revenue:

Research revenue for the three months ended January 31, 2025 increased $11.3 million, or 4%, as compared with the prior year on a reported basis. On a constant currency basis, Research revenue increased 5% as compared with the prior year. This increase was due to a content rights project for training GenAI large language models, author funded open access and, to a lesser extent, audience solutions, partially offset by institutional models. In the three months ended January 31, 2025 we recognized $9 million of GenAI revenue due to expanding a previously executed content licensing project for training. On a constant currency basis excluding GenAI revenue, Research revenue increased 2% as compared with the prior year. Open access article output growth was approximately 12% as compared with the prior year.

Adjusted EBITDA:

On a constant currency basis, Adjusted EBITDA increased 12% as compared with the prior year. This increase was primarily due to higher revenue, partially offset by higher employment costs.

INDEX

LEARNING Revenue: Three Months Ended January 31, 2025 2024 % Change Favorable (Unfavorable) Constant Currency % Change Favorable (Unfavorable)
Academic $78,795 $87,216 (10)% (9)%
Professional 58,287 59,118 (1)% (1)%
Total Learning Revenue 137,082 146,334 (6)% (6)%
Cost of Sales 35,062 38,744 10% 9%
Operating Expenses 62,249 67,794 8% 8%
Amortization of Intangible Assets 2,007 2,283 12% 12%
Adjusted Operating Income 37,764 37,513 1% 1%
Depreciation and amortization 10,761 13,812 22% 22%
Adjusted EBITDA $48,525 $51,325 (5)% (5)%
Adjusted EBITDA Margin 35.4% 35.1%

Revenue:

Learning revenue decreased $9.3 million, or 6%, as compared with the prior year on a reported basis. On a constant currency basis, revenue decreased 6% as compared with the prior year. Academic revenue decreased due to lower licensing revenue and, to a lesser extent, a decrease in digital content sales, partially offset by an increase in zyBooks digital courseware. Professional revenue decreased due to lower licensing revenue, partially offset by an increase in print and digital content sales.

Adjusted EBITDA:

On a constant currency basis, Adjusted EBITDA decreased 5% as compared with the prior year. This decrease was primarily due to lower revenues and, to a lesser extent, an increase in employee costs, partially offset by lower royalty costs and a decrease in technology related costs.

INDEX

HELD FOR SALE OR SOLD Three Months Ended January 31, 2025 2024 % Change Favorable (Unfavorable) Constant Currency % Change Favorable (Unfavorable)
Total Held for Sale or Sold Revenue $— $58,172 # #
Cost of Sales — 35,012 # #
Operating Expenses — 19,042 # #
Adjusted Operating Income — 4,118 # #
Depreciation and amortization — — # #
Adjusted EBITDA $— $4,118 # #
Adjusted EBITDA Margin 0.0% 7.1%

# Not meaningful

Revenue:

Revenue for Held for Sale or Sold decreased $58.2 million as compared with the prior year due to the sale of the University Services, Wiley Edge, and CrossKnowledge businesses.

Adjusted EBITDA:

On a constant currency basis, Adjusted EBITDA decreased $4.1 million as compared with the prior year due to the sale of the University Services, Wiley Edge, and CrossKnowledge businesses.

CORPORATE EXPENSES Three Months Ended January 31, 2025 2024 % Change Favorable (Unfavorable) Constant Currency % Change Favorable (Unfavorable)
Operating Expenses $45,710 $48,578 6% 6%
Amortization of Intangible Assets 318 — # #
Adjusted Corporate Expenses (46,028) (48,578) 5% 5%
Depreciation and amortization 3,795 9,633 61% 61%
Adjusted EBITDA $(42,233) $(38,945) (8)% (9)%

# Not meaningful

On a constant currency basis, adjusted corporate expenses of $42.2 million on an Adjusted EBITDA basis increased 9% with the prior year. This was primarily due to an increase in enterprise modernization and consulting fees related to strategic initiatives, including the re-engineering of our cost structure.

RESULTS OF OPERATIONS – NINE MONTHS ENDED JANUARY 31, 2025

NINE MONTHS SUMMARY

  • US GAAP Results: Consolidated Revenue of $1,235.0 million (-12%, compared with the prior year), Operating Income of $144.9 million (+$161.5 million, compared with the prior year operating loss), and Diluted Earnings per Share of $0.29 ($+4.39 per share, compared with the prior year diluted loss per share).
  • Adjusted Results at Constant Currency (excluding Held for Sale or Sold segment results): Adjusted Revenue of $1,217.6 million (+3%, compared with the prior year), Adjusted Operating Income of $161.6 million (+38%, compared with the prior year), Adjusted EBITDA of $272.0 million (+12%, compared with the prior year), and Adjusted EPS of $2.28 (+43%, compared with the prior year).

CONSOLIDATED RESULTS OF OPERATIONS

Revenue:

Revenue for the nine months ended January 31, 2025, decreased $169.5 million, or 12%, as compared with the prior year. On a constant currency basis, revenue decreased 12% as compared with the prior year.

Excluding the revenues from the Held for Sale or Sold segment, Adjusted Revenue increased 3% on a constant currency basis.

On a constant currency basis excluding $30 million in content rights projects for training GenAI large language models, Adjusted Revenue for the nine months ended January 31, 2025 increased 1% as compared with the prior year.

Adjusted Revenue

Below is a reconciliation of our consolidated US GAAP Revenue, net to Non-GAAP Adjusted Revenue, net:

Nine Months Ended January 31, 2025 2024
US GAAP Revenue, net $1,235,030 $1,404,526
Less: Held for Sale or Sold segment (1) (17,382) (228,259)
Non-GAAP Adjusted Revenue, net $1,217,648 $1,176,267

(1) Our Adjusted Revenue, net excludes the impact of our Held for Sale or Sold segment revenue.

See the “Segment Operating Results” below for additional details on each segment’s revenue and Adjusted EBITDA performance.

Cost of Sales:

Cost of sales for the nine months ended January 31, 2025 of $320.4 million decreased $135.9 million, or 30%, as compared with the prior year. On a constant currency basis, cost of sales decreased 30% as compared with the prior year. This was primarily due to the prior year including employee and marketing costs related to the University Services business which was sold on January 1, 2024 and, to a lesser extent, lower employee costs related to the Wiley Edge business which was sold on May 31, 2024.

Excluding the cost of sales from the Held for Sale or Sold segment, cost of sales decreased 2% as compared with the prior year on a constant currency basis primarily due to lower product development and inventory related costs, partially offset by higher royalty costs in Learning.

Operating and Administrative Expenses:

Operating and administrative expenses for the nine months ended January 31, 2025 of $717.7 million decreased $43.8 million, or 6% as compared with the prior year. On a constant currency basis, operating and administrative expenses decreased 6% as compared with the prior year primarily reflecting lower employee related costs and, to a lesser extent, lower depreciation and amortization, and technology related costs, partially offset by higher professional fees.

Excluding operating and administrative expenses from the Held for Sale or Sold segment, operating and administrative expenses on a constant currency basis was consistent with the prior year primarily due to higher professional fees and, to a lesser extent, travel and entertainment costs, offset by lower depreciation and amortization, technology related costs, and employment costs.

Impairment of Goodwill:

We recorded an impairment of goodwill for the nine months ended January 31, 2024, of $108.4 million. This charge is reflected in the Impairment of goodwill in the Unaudited Condensed Consolidated Statements of Net (Loss) Income.

As a result of signing the Edge Agreement and the decrease in the fair value of the business, we tested the goodwill of the Wiley Edge reporting unit within the Held for Sale or Sold segment for impairment. We concluded that the carrying value of the Wiley Edge reporting unit was above its fair value which resulted in a pretax noncash goodwill impairment of approximately $81.7 million. Such impairment reduced the goodwill of the Wiley Edge reporting unit to zero.

In accordance with applicable accounting standards, we were required to test goodwill for impairment immediately before and after our segment realignment in the three months ended July 31, 2023. Prior to the realignment, we concluded that the fair value of the University Services reporting unit within the former Academic segment was below its carrying value, which resulted in a pretax noncash goodwill impairment of $11.4 million.

After the realignment, we concluded that the fair value of the CrossKnowledge reporting unit within the Held for Sale or Sold segment was below its carrying value, which resulted in a pretax noncash goodwill impairment of $15.3 million.

Restructuring and Related Charges:

We recorded restructuring and related charges in the nine months ended January 31, 2025 and 2024 of $13.1 million and $52.0 million, respectively. These charges are reflected in Restructuring and related charges on our Unaudited Condensed Consolidated Statements of Net (Loss) Income.

Global Restructuring Program

For the nine months ended January 31, 2025 and 2024, we recorded pretax restructuring charges of $16.8 million and $50.9 million, respectively, related to this program.

See Note 9, “Restructuring and Related Charges” for more details on the Global Restructuring Program charges.

Business Optimization Program

For the nine months ended January 31, 2025 and 2024, we recorded pretax restructuring credits of $(3.8) million and charges of $1.1 million, respectively, related to this program.

See Note 9, “Restructuring and Related Charges” for more details on the Business Optimization Program credits and charges.

For the impact of our restructuring programs on diluted earnings (loss) per share, see the section below, “Diluted Earnings (Loss) per Share.”

Amortization of Intangible Assets:

Amortization of intangible assets was $38.9 million for the nine months ended January 31, 2025, a decrease of $3.8 million, or 9%, as compared with the prior year. On a constant currency basis, amortization of intangible assets decreased 9% as compared with the prior year primarily due to the cessation of amortization for held-for-sale assets and, to a lesser extent, the completion of amortization of certain acquired intangible assets. See Note 3, “Divestitures” for more details on these divestitures.

Operating Income, Adjusted Operating Income (OI) and Adjusted EBITDA:

Operating income of $144.9 million for the nine months ended January 31, 2025, increased $161.5 million compared with the prior year loss of $16.5 million. The increase was primarily due to a goodwill impairment in the nine months ended January 31, 2024, lower costs of sales and, to a lesser extent, lower operating and administrative expenses, and restructuring charges, partially offset by a decrease in revenue.

Adjusted OI on a constant currency basis increased 38% as compared with the prior year. The increase in Adjusted OI was primarily due to an increase in Adjusted Revenue and, to a lesser extent, lower costs of sales, partially offset by higher operating and administrative expenses.

Adjusted EBITDA on a constant currency basis increased 12% as compared with the prior year primarily due to an increase in Adjusted Revenue, partially offset by higher operating and administrative expenses.

Adjusted OI

Below is a reconciliation of our consolidated US GAAP Operating Income (Loss) to Non-GAAP Adjusted OI:

Nine Months Ended January 31, 2025 2024
US GAAP Operating Income (Loss) $144,937 $(16,521)
Adjustments:
Restructuring and related charges 13,071 52,033
Impairment of goodwill — 108,449
Held for Sale or Sold segment Adjusted Operating Loss (Income)(1) 3,578 (26,302)
Non-GAAP Adjusted OI $161,586 $117,659

(1) Our Adjusted OI excludes the impact of our Held for Sale or Sold segment Adjusted Operating Loss or (Income).

Adjusted EBITDA

Below is a reconciliation of our consolidated US GAAP Net Income (Loss) to Non-GAAP EBITDA and Adjusted EBITDA:

Nine Months Ended January 31, 2025 2024
Net Income (Loss) $16,068 $(225,584)
Interest expense 41,277 37,592
Provision (benefit) for income taxes 74,545 (15,465)
Depreciation and amortization 110,445 129,376
Non-GAAP EBITDA 242,335 (74,081)
Impairment of goodwill — 108,449
Restructuring and related charges 13,071 52,033
Net foreign exchange transaction losses 7,316 3,489
Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale 9,760 179,747
Other (income) expense, net (4,029) 3,700
Held for Sale or Sold segment Adjusted EBITDA (1) 3,578 (29,739)
Non-GAAP Adjusted EBITDA $272,031 $243,598

(1) Our Non-GAAP Adjusted EBITDA excludes the Held for Sale or Sold segment Non-GAAP Adjusted EBITDA.

Interest Expense:

Interest expense for the nine months ended January 31, 2025, was $41.3 million compared with the prior year of $37.6 million. This increase was primarily due to a higher weighted average effective interest rate.

Net Foreign Exchange Transaction Losses:

Net foreign exchange transaction losses of $(7.3) million for the nine months ended January 31, 2025 were primarily due to losses on our foreign currency denominated intercompany accounts receivable and payable balances and, to a lesser extent, on our foreign currency denominated third party accounts receivable and payable balances due to the impact of the change in average foreign exchange rates as compared to the US dollar. In the nine months ended January 31, 2025, we wrote off an additional net $0.4 million in cumulative translation adjustments in earnings due to the closure of our operations in Russia.

Foreign exchange transaction losses of $(3.5) million for the nine months ended January 31, 2024 were primarily due to losses on our foreign currency denominated third-party receivable and payable balances and, to a lesser extent, losses on our intercompany accounts receivable and payable balances due to the impact of the change in average foreign exchange rates as compared to the US dollar. In fiscal year 2023, due to the closure of our operations in Russia, our Russian entity was deemed substantially liquidated. As a result, cumulative translation adjustments associated with that entity were recognized. In the nine months ended January 31, 2024, we wrote off an additional net $0.8 million in cumulative translation adjustments from our Russian entity.

Net Loss on Sale of Businesses, Assets, and Impairment Charges Related to Assets Held-for-Sale:

For the nine months ended January 31, 2025 and 2024, we recorded net pretax loss on sale of businesses, assets, and impairment charges related to assets held-for-sale as follows:

Nine Months Ended January 31, 2025 2024
CrossKnowledge $4,197 $(56,159)
Wiley Edge (14,778) (20,676)
University Services 850 (101,412)
Tuition Manager 120 (1,500)
Sale of assets (149) —
Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale $(9,760) $(179,747)

These charges are reflected in Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale on our Unaudited Condensed Consolidated Statements of Net (Loss) Income. See above in the Consolidated Results of Operations for the three months ended January 31, 2025 for more details related to the nine months ended January 31, 2025 for CrossKnowledge, Wiley Edge and University Services.

In the nine months ended January 31, 2025, there was a reduction in the pretax loss on the sale of our Tuition Manager business previously in our Held for Sale or Sold segment of $0.1 million due to a selling price adjustment for cash received after the closing.

In the nine months ended January 31, 2025 we sold a facility which was reflected in Technology, property, and equipment, net in our Unaudited Condensed Consolidated Statements of Financial Position which resulted in a pretax loss on sale of $0.2 million.

In the nine months ended January 31, 2024, we recorded a held-for-sale pretax impairment of $76.8 million which includes $20.6 million for Wiley Edge and $56.2 million for CrossKnowledge. The losses on sale of businesses is due to the sale of our University Services and Tuition Manager businesses previously in our Held for Sale or Sold segment, which resulted in a pretax loss of approximately $101.4 million and $1.5 million, respectively, during the nine months ended January 31, 2024.

See Note 3, “Divestitures” for more details on the divestitures.

Provision (Benefit) for Income Taxes:

Below is a reconciliation of our US GAAP Income (Loss) Before Taxes to Non-GAAP Adjusted Income Before Taxes:

Nine Months Ended January 31, 2025 2024
US GAAP Income (Loss) Before Taxes $90,613 $(241,049)
Pretax Impact of Adjustments:
Impairment of goodwill — 108,449
Restructuring and related charges 13,071 52,033
Foreign exchange losses on intercompany transactions, including the write off of certain cumulative translation adjustments 5,590 1,089
Amortization of acquired intangible assets 38,956 44,550
Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale 9,760 179,747
Held for Sale or Sold segment Adjusted Loss (Income) Before Taxes (1) 3,578 (28,253)
Non-GAAP Adjusted Income Before Taxes $161,568 $116,566

(1) Our Adjusted Income Before Taxes excludes the Adjusted Loss (Income) Before Taxes of our Held for Sale or Sold segment.

Below is a reconciliation of our US GAAP Income Tax Provision (Benefit) to Non-GAAP Adjusted Income Tax Provision, including our US GAAP Effective Tax Rate and our Non-GAAP Adjusted Effective Tax Rate:

Nine Months Ended January 31, 2025 2024
US GAAP Income Tax Provision (Benefit) $74,545 $(15,465)
Income Tax Impact of Adjustments(1):
Impairment of goodwill — 2,697
Restructuring and related charges 1,315 13,237
Foreign exchange losses on intercompany transactions, including the write off of certain cumulative translation adjustments 599 112
Amortization of acquired intangible assets 5,511 8,668
Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale (1,360) 25,711
Held for Sale or Sold segment Adjusted Tax Benefit (Provision)(2) 887 (6,518)
Income Tax Adjustments
Impact of valuation allowance on the US GAAP effective tax rate(3) (44,863) —
Non-GAAP Adjusted Income Tax Provision $36,634 $28,442
US GAAP Effective Tax Rate 82.3% 6.4%
Non-GAAP Adjusted Effective Tax Rate 22.7% 24.4%

(1) For the nine months ended January 31, 2025 and 2024, substantially all of the tax impact was from deferred taxes.

(2) Our Adjusted Income Tax Provision excludes the Adjusted Tax Benefit (Provision) of our Held for Sale or Sold segment.

(3) In the nine months ended January 31, 2025, there was a $44.9 million impact on the US GAAP effective tax rate due to the valuation allowance on deferred tax assets in the US.

53

The US GAAP effective tax rate for the nine months ended January 31, 2025, was 82.3% compared to 6.4% for the nine months ended January 31, 2024. The US GAAP effective tax rate for the nine months ended January 31, 2025 was greater than the US GAAP effective tax rate for the nine months ended January 31, 2024 primarily driven by US ordinary losses for which no tax benefit can be recognized as a result of the valuation allowance recorded against the net deferred tax assets.

The Non-GAAP Adjusted Effective Tax Rate was 22.7% for the nine months ended January 31, 2025 compared to 24.4% for the nine months ended January 31, 2024. The decrease in the Non-GAAP Adjusted Effective Tax Rate for the nine months ended January 31, 2025 compared with the nine months ended January 31, 2024 was primarily due to the mix of income and the impact of a discrete item related to the release of a tax reserve.

Diluted Earnings (Loss) per Share:

Diluted earnings per share for the nine months ended January 31, 2025 was $0.29 per share compared with a loss per share of $(4.10) per share for the nine months ended January 31, 2024. This increase was primarily due to net loss on sale of businesses and impairment charges related to assets held-for-sale in the prior year, and an increase in operating income, partially offset by an income tax benefit in the prior year compared to an income tax provision in the nine months ended January 31, 2025.

Below is a reconciliation of our US GAAP Earnings (Loss) per Share to Non-GAAP Adjusted EPS. The amount of the pretax, and the related income tax impact for the adjustments included in the table below are presented in the section above, “Provision (Benefit) for Income Taxes.”

Nine Months Ended January 31, 2025 2024
US GAAP Earnings (Loss) Per Share $0.29 $(4.10)
Adjustments:
Impairment of goodwill — 1.90
Restructuring and related charges 0.21 0.70
Foreign exchange losses on intercompany transactions, including the write off of certain cumulative translation adjustments 0.09 0.02
Amortization of acquired intangible assets 0.62 0.65
Net loss on sale of businesses, assets, and impairment charges related to assets held-for-sale 0.20 2.77
Held for Sale or Sold segment Adjusted Net Loss (Income)(1) 0.05 (0.39)
Income tax adjustments 0.82 —
EPS impact of using weighted-average dilutive shares for adjusted EPS calculation (2) — 0.04
Non-GAAP Adjusted EPS $2.28 $1.59

(1) Our Adjusted EPS excludes the Adjusted Net Loss (Income) of our Held for Sale or Sold segment.

(2) Represents the impact of using diluted weighted-average number of common shares outstanding (55.6 million shares for the nine months ended January 31, 2024) included in the Non-GAAP Adjusted EPS calculation in order to apply the dilutive impact on adjusted net income due to the effect of unvested restricted stock units and other stock awards. This impact occurs when a US GAAP net loss is reported and the effect of using dilutive shares is antidilutive.

On a constant currency basis, Adjusted EPS increased 43% primarily due to an increase in Adjusted Operating Income and, to a lesser extent, an increase in interest income.

SEGMENT OPERATING RESULTS

RESEARCH Revenue: Nine Months Ended January 31, 2025 2024 % Change Favorable (Unfavorable) Constant Currency % Change Favorable (Unfavorable)
Research Publishing $679,492 $659,329 3% 3%
Research Solutions 115,246 112,344 3% 3%
Total Research Revenue 794,738 771,673 3% 3%
Cost of Sales 207,406 211,472 2% 2%
Operating Expenses 374,075 356,825 (5)% (5)%
Amortization of Intangible Assets 32,845 33,895 3% 3%
Adjusted Operating Income 180,412 169,481 6% 7%
Depreciation and amortization 66,999 67,909 1% 2%
Adjusted EBITDA $247,411 $237,390 4% 5%
Adjusted EBITDA Margin 31.1% 30.8%

Revenue:

Research revenue for the nine months ended January 31, 2025 increased $23.1 million, or 3%, as compared with the prior year on a reported basis. On a constant currency basis, Research revenue increased 3% as compared with the prior year. This was primarily due to an increase in author funded open access, content rights projects for training GenAI large language models of $10.1 million, and an increase in institutional models, partially offset by a decrease in legacy print and licensing revenue. On a constant currency basis, excluding GenAI revenue Research revenue increased 2% as compared with the prior year. Open access article output growth was approximately 14% as compared with the prior year.

Adjusted EBITDA:

On a constant currency basis, Adjusted EBITDA increased 5% as compared with the prior year. This increase was primarily due to higher revenue and, to a lesser extent, lower cost of sales, partially offset by higher employment related costs and, to a lesser extent, higher professional fees.

INDEX

LEARNING Revenue: Nine Months Ended January 31, 2025 2024 % Change Favorable (Unfavorable) Constant Currency % Change Favorable (Unfavorable)
Academic $233,547 $224,633 4% 4%
Professional 189,363 179,961 5% 5%
Total Learning Revenue 422,910 404,594 5% 4%
Cost of Sales 105,278 105,685 0% 1%
Operating Expenses 195,424 207,026 6% 6%
Amortization of Intangible Assets 6,073 6,832 11% 11%
Adjusted Operating Income 116,135 85,051 37% 36%
Depreciation and amortization 32,952 41,338 20% 20%
Adjusted EBITDA $149,087 $126,389 18% 17%
Adjusted EBITDA Margin 35.3% 31.2%

Revenue:

Learning revenue increased $18.3 million, or 5%, as compared with the prior year on a reported basis. On a constant currency basis, revenue increased 4% as compared with the prior year. Academic revenue on a constant currency basis increased 4% primarily due to $11 million in content rights projects for training GenAI large language models and, to a lesser extent, an increase in zyBooks digital courseware, partially offset by a decrease in print book and digital content sales. Professional revenue on a constant currency basis increased 5% as compared with the prior year primarily due to an increase in GenAI revenue of $8 million and, to a lesser extent, an increase in print book sales, partially offset by a decrease in licensing revenue, and digital content sales. On a constant currency basis excluding GenAI revenue, Learning revenue decreased 1% as compared with the prior year.

Adjusted EBITDA:

On a constant currency basis, Adjusted EBITDA increased 17% as compared with the prior year. This increase was primarily due to higher revenue and, to a lesser extent, a decrease in employee costs after recent restructuring actions, partially offset by higher royalty costs.

INDEX

HELD FOR SALE OR SOLD Nine Months Ended January 31, 2025 2024 % Change Favorable (Unfavorable) Constant Currency % Change Favorable (Unfavorable)
Total Held for Sale or Sold Revenue $17,382 $228,259 (92)% (92)%
Cost of Sales 7,755 139,220 94% 94%
Operating Expenses 13,205 60,734 78% 78%
Amortization of Intangible Assets — 2,003 # #
Adjusted Operating (Loss) Income (3,578) 26,302 # #
Depreciation and amortization — 3,437 # #
Adjusted EBITDA $(3,578) $29,739 # #
Adjusted EBITDA Margin (20.6)% 13.0%

# Not meaningful

Revenue:

Revenue for Held for Sale or Sold decreased $210.9 million, or 92%, as compared with the prior year on a reported and constant currency basis. This was primarily due to the sale of the University Services, Wiley Edge, and CrossKnowledge businesses.

Adjusted EBITDA:

On a constant currency basis, Adjusted EBITDA decreased $33.3 million as compared with the prior year. This decrease was primarily due to the sale of the University Services, Wiley Edge, and CrossKnowledge businesses.

CORPORATE EXPENSES Nine Months Ended January 31, 2025 2024 % Change Favorable (Unfavorable) Constant Currency % Change Favorable (Unfavorable)
Operating Expenses $134,966 $136,873 1% 2%
Amortization of Intangible Assets (5) — # #
Adjusted Corporate Expenses (134,961) (136,873) 1% 2%
Depreciation and amortization 10,494 16,692 37% 37%
Adjusted EBITDA $(124,467) $(120,181) (4)% (3)%

# Not meaningful

On a constant currency basis, adjusted corporate expenses of $124.5 million on an Adjusted EBITDA basis increased 3% as compared with the prior year. This was primarily due to an increase in enterprise modernization and consulting fees related to strategic initiatives, including the re-engineering of our cost structure.

ACCOUNTING STANDARDS UPDATE

We are required to prepare our Unaudited Condensed Consolidated Financial Statements in accordance with the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) which is the source for all authoritative US GAAP. The FASB ASC is subject to updates by the FASB, which are known as Accounting Standards Updates (ASU). See Note 2, "Recent Accounting Standards" of Part I, Item 1, "Notes to Unaudited Condensed Consolidated Financial Statements" for further information.

LIQUIDITY AND CAPITAL RESOURCES

Principal Sources of Liquidity

We believe that our operating cash flow, together with our revolving credit facilities and other available debt financing, will be adequate to meet our operating, investing, and financing needs in the next twelve months. Operating cash flow provides the primary source of cash to fund operating needs and capital expenditures. Excess operating cash is used to fund shareholder dividends. Other discretionary uses of cash flow include share repurchases and acquisitions to complement our portfolio of businesses. As necessary, we may supplement operating cash flow with debt to fund these activities. The overall cash position of the Company reflects our durable business results and a global cash management strategy that considers liquidity management, economic factors and tax considerations. Our cash and cash equivalents are maintained at a number of financial institutions. To mitigate the risk of uninsured balances, we select financial institutions based on their credit ratings and financial strength, and we perform ongoing evaluations of these institutions to limit our concentration risk exposure to any financial institution.

As of January 31, 2025, we had cash and cash equivalents of $104.5 million, of which approximately all was located outside the US. Maintenance of these cash and cash equivalent balances outside the US does not have a material impact on the liquidity or capital resources of our operations. We intend to repatriate earnings from our non-US subsidiaries, and to the extent we repatriate these funds to the US, we will be required to pay income taxes in various US state and local jurisdictions and applicable non-US withholding or similar taxes in the periods in which such repatriation occurs. Accordingly, as of January 31, 2025, we have recorded a deferred tax liability of approximately $3.1 million related to the estimated taxes that would be incurred upon repatriating certain non-US earnings to the US.

On November 30, 2022, we entered into the second amendment to the Third Amended and Restated Credit Agreement (collectively, the Amended and Restated CA). See Note 15, “Debt and Available Credit Facilities” for more details on the amendment. The Amended and Restated CA provided for senior unsecured credit facilities comprised of the following (i) a five-year revolving credit facility in an aggregate principal amount up to $1.115 billion, which matures November 2027, (ii) a five-year term loan A facility consisting of $200 million, which matures November 2027, and (iii) $185 million aggregate principal amount revolving credit facility which matured in May 2024.

As of January 31, 2025, we had approximately $887.2 million of debt outstanding, net of unamortized issuance costs of $0.5 million, and approximately $415.6 million of unused borrowing capacity under our Amended and Restated CA and other facilities. Our Amended and Restated CA contains certain restrictive covenants related to our consolidated leverage ratio and interest coverage ratio, which we were in compliance with as of January 31, 2025.

Analysis of Historical Cash Flows

The following table shows the changes in our Unaudited Condensed Consolidated Statements of Cash Flows.

Nine Months Ended January 31, 2025 2024
Net cash provided by operating activities $52,250 $24,352
Net cash used in investing activities (69,694) (78,493)
Net cash provided by financing activities 24,076 55,354
Effect of foreign currency exchange rate changes on cash, cash equivalents and restricted cash $(1,615) $432

Cash flow from operations is seasonally a use of cash in the first half of Wiley’s fiscal year principally due to the timing of collections for annual journal subscriptions, which typically occurs in the beginning of the second half of our fiscal year.

Free cash flow less product development spending helps assess our ability, over the long term, to create value for our shareholders, as it represents cash available to repay debt, pay common dividends, and fund share repurchases, and acquisitions. Below are the details of Free cash flow less product development spending.

Free Cash Flow less Product Development Spending:

Nine Months Ended January 31, 2025 2024
Net cash provided by operating activities $52,250 $24,352
Less: Additions to technology, property and equipment (42,347) (57,275)
Less: Product development spending (11,054) (12,324)
Free cash flow less product development spending $(1,151) $(45,247)

Net Cash Provided by Operating Activities

The following is a summary of the $27.9 million change in Net cash provided by operating activities for the nine months ended January 31, 2025 compared with the nine months ended January 31, 2024 (amounts in millions).

Net cash provided by operating activities – Nine months ended January 31, 2024 $24.4
Net income adjusted for items to reconcile net income to net cash provided by operating activities, which would include such noncash items as depreciation and amortization, impairment of goodwill, net losses on sale of businesses, assets, and impairment charges related to assets held-for-sale, restructuring charges, and the change in deferred taxes (38.6)
Working capital changes:
Accounts receivable, net and contract liabilities 23.0
Accounts payable and accrued royalties 41.5
Changes in other assets and liabilities 2.0
Net cash provided by operating activities – Nine months ended January 31, 2025 $52.3

The favorable change in accounts receivable, net and contract liabilities was primarily due to higher collections for institutional models and open access due to higher revenue.

The favorable change in accounts payable and accrued royalties was primarily due to the timing of payments.

The favorable changes in other assets and liabilities noted in the table above was primarily due to lower restructuring payments, and an increase in income taxes payable, partially offset by higher payments for annual incentive compensation in fiscal year 2025 related to the prior fiscal year and, to a lesser extent, other operating liabilities.

Our negative working capital (current assets less current liabilities) was $322.5 million and $419.2 million as of January 31, 2025 and April 30, 2024, respectively. This $96.7 million change in negative working capital was primarily due to the seasonality of our business. The primary driver of the negative working capital is the benefit realized from unearned contract liabilities related to subscriptions for which cash has been collected in advance. The contract liabilities will be recognized as income when the products are shipped or made available online to the customers over the term of the subscription. Current liabilities as of January 31, 2025 and as of April 30, 2024 includes $313.3 million and $483.8 million, respectively, primarily related to deferred subscription revenue for which cash was collected in advance.

Cash collected in advance for subscriptions is used by us for a number of purposes, including funding operations, capital expenditures, acquisitions, debt repayments, dividend payments, and share repurchases.

Net Cash Used In Investing Activities

Net cash used in investing activities for the nine months ended January 31, 2025 was $69.7 million compared to $78.5 million in the prior year. The decrease in net cash used in investing activities was primarily due to a decrease in cash used of $14.9 million for additions to technology, property and equipment, partially offset by the net cash transferred in fiscal year 2025 related to the sale of businesses and assets. See Note 3, "Divestitures" for further details.

Net Cash Provided By Financing Activities

Net cash provided by financing activities was $24.1 million for the nine months ended January 31, 2025 compared to $55.4 million for the nine months ended January 31, 2024. This decrease in cash provided by financing activities was primarily due to lower net borrowings in fiscal year 2025 of $44.4 million, partially offset by the $17.5 million change in book overdrafts.

In the nine months ended January 31, 2025, we increased our quarterly dividend to shareholders to $1.41 per share annualized versus $1.40 per share annualized in the prior year.

The following table summarizes the shares repurchased of Class A and Class B Common Stock (shares in thousands):

Nine Months Ended January 31, 2025 2024
Shares repurchased – Class A 782 870
Shares repurchased – Class B 2 2
Average price – Class A and Class B $44.66 $33.24

The average price per share excludes excise taxes payable on share repurchases and may differ from the share repurchases reflected in Purchases of treasury shares in our Unaudited Condensed Consolidated Statements of Cash Flows.

Market risk

As filed, 6,326 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

We are exposed to market risk primarily related to interest rates, foreign exchange, and credit risk. It is our policy to monitor these exposures and to use derivative financial investments and/or insurance contracts from time to time to reduce fluctuations in earnings and cash flows when it is deemed appropriate to do so. We do not use derivative financial instruments for trading or speculative purposes.

Interest Rates

From time to time, we may use interest rate swaps, collars, or options to manage our exposure to fluctuations in interest rates. It is management’s intention that the notional amount of interest rate swaps be less than the variable rate loans outstanding during the life of the derivatives.

The information set forth in Note 16, “Derivatives Instruments and Hedging Activities,” of the Notes to Unaudited Condensed Consolidated Financial Statements under the caption “Interest Rate Contracts,” is incorporated herein by reference.

On an annual basis, a hypothetical one percent change in interest rates for the $387.7 million of unhedged variable rate debt as of January 31, 2025 would affect net income and cash flow by approximately $3.0 million.

Foreign Exchange Rates

Fluctuations in the currencies of countries where we operate outside the US may have a significant impact on financial results. We are primarily exposed to movements in British pound sterling, euros, Canadian and Australian dollars, and certain currencies in Asia. The statements of financial position of non-US business units are translated into US dollars using period-end exchange rates for assets and liabilities and the statements of income are translated into US dollars using weighted-average exchange rates for revenues and expenses.

Our significant investments in non-US businesses are exposed to foreign currency risk. Adjustments resulting from translating assets and liabilities are reported as a separate component of Accumulated other comprehensive loss, net of tax within Shareholders’ Equity under the caption Foreign currency translation adjustment.

During the three months ended January 31, 2025, we recorded foreign currency translation losses in Accumulated other comprehensive loss, net of tax of approximately $(32.2) million primarily as a result of the fluctuations of the US dollar relative to the British pound sterling. During the nine months ended January 31, 2025, we recorded foreign currency translation gains in Accumulated other comprehensive loss, net of tax of approximately $10.7 million, primarily as a result of the fluctuations of the US dollar relative to the euro, partially offset by fluctuations of the US dollar relative to the British pound sterling. During the three months ended January 31, 2024, we recorded foreign currency translation gains in Accumulated other comprehensive loss, net of tax of approximately $25.1 million primarily as a result of the fluctuations of the US dollar relative to the British pound sterling and, to a lesser extent, the euro. During the nine months ended January 31, 2024, we recorded foreign currency translation gains in Accumulated other comprehensive loss, net of tax of approximately $2.4 million, primarily as a result of the fluctuations of the US dollar relative to the British pound sterling, partially offset by fluctuations of the US dollar relative to the euro.

Exchange rate gains or losses related to foreign currency transactions are recognized as transaction gains or losses on the Unaudited Condensed Consolidated Statements of Net (Loss) Income as incurred. Under certain circumstances, we may enter into derivative financial instruments in the form of foreign currency forward contracts to hedge against specific transactions, including intercompany purchases and loans.

The information set forth in Note 16, “Derivatives Instruments and Hedging Activities,” of the Notes to Unaudited Condensed Consolidated Financial Statements under the caption “Foreign Currency Contracts,” is incorporated herein by reference.

Sales Return Reserves

The estimated allowance for print book sales returns is based upon historical return patterns, as well as current market trends in the businesses in which we operate. In connection with the estimated sales return reserves, we also include a related increase to inventory and a reduction to accrued royalties as a result of the expected returns.

The reserves are reflected in the following accounts of our Unaudited Condensed Consolidated Statements of Financial Position:

January 31, 2025 April 30, 2024
Increase in Inventories, net $6,163 $7,833
Decrease in Accrued royalties $(2,421) $(3,112)
Increase in Contract liabilities $19,588 $25,393
Print book sales return reserve net liability balance $(11,004) $(14,448)

A one percent change in the estimated sales return rate could affect net income by approximately $0.9 million. A change in the pattern or trends in returns could affect the estimated allowance.

Customer Credit Risk

In the journal publishing business, some subscriptions are sourced through journal subscription agents who, acting as agents for library customers, facilitate ordering by consolidating the subscription orders/billings of each subscriber with various publishers. Cash is generally collected in advance from subscribers by the subscription agents and is principally remitted to us between the months of December and April. Although currently we have minimal credit risk exposure to these agents, future calendar-year subscription receipts from these agents are highly dependent on their financial condition and liquidity. Subscription agents account for approximately 16% of total annual consolidated revenue, and no one affiliated group of subscription agents accounts for more than 10% of total annual consolidated revenue.

Our book business is not dependent upon a single customer; however, the industry is concentrated in national, regional, and online bookstore chains. No single book customer accounts for more than 7% of total consolidated revenue and 20% of accounts receivable at January 31, 2025. The top 10 book customers account for approximately 13% of total consolidated revenue and approximately 34% of accounts receivable at January 31, 2025.

Controls and procedures

As filed, 1,346 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The Company’s Chief Executive Officer and Interim Chief Financial Officer, together with other members of the Company’s management, have conducted an evaluation of the Company’s disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”) as of the end of the period covered by this report. Based on this evaluation, the Chief Executive Officer and Interim Chief Financial Officer have concluded that the Company's disclosure controls and procedures were effective to ensure that information required to be disclosed by the Company in reports filed or submitted under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission's rules and forms and (ii) accumulated and communicated to the Company’s management, including its Chief Executive Officer and Interim Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) during the quarter ended January 31, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 450 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the fiscal year ended April 30, 2024, that if they were to occur, could materially adversely affect our businesses, consolidated financial condition, and results of operations. For a discussion of our risk factors, refer to Item 1A. “Risk Factors” contained in our Annual Report on Form 10-K for the fiscal year ended April 30, 2024.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2025-01-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2024-11-01 to 2025-01-31$404.6mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2024-05-01 to 2025-01-31$1.24bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2024-11-01 to 2025-01-31$104.2mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue9 months2024-05-01 to 2025-01-31$320.4mus-gaap:CostOfGoodsAndServicesSold
Selling, general and administrative3 months2024-11-01 to 2025-01-31$230.0mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2024-05-01 to 2025-01-31$717.7mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2024-11-01 to 2025-01-31$51.8mus-gaap:OperatingIncomeLoss
Operating income9 months2024-05-01 to 2025-01-31$144.9mus-gaap:OperatingIncomeLoss
Interest expense3 months2024-11-01 to 2025-01-31$14.0mus-gaap:InterestExpenseNonoperating
Interest expense9 months2024-05-01 to 2025-01-31$41.3mus-gaap:InterestExpenseNonoperating
Income tax3 months2024-11-01 to 2025-01-31$41.6mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2024-05-01 to 2025-01-31$74.5mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2024-11-01 to 2025-01-31−$23.0mus-gaap:NetIncomeLoss
Net income9 months2024-05-01 to 2025-01-31$16.1mus-gaap:NetIncomeLoss
Diluted EPS3 months2024-11-01 to 2025-01-31−$0.43us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2024-05-01 to 2025-01-31$0.29us-gaap:EarningsPerShareDiluted
Basic EPS3 months2024-11-01 to 2025-01-31−$0.43us-gaap:EarningsPerShareBasic
Basic EPS9 months2024-05-01 to 2025-01-31$0.30us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2024-11-01 to 2025-01-3153,952,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2024-05-01 to 2025-01-3154,815,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2024-05-01 to 2025-01-31$52.3mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2024-05-01 to 2025-01-31$42.3mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid9 months2024-05-01 to 2025-01-31$57.2mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases9 months2024-05-01 to 2025-01-31$35.4mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2025-01-31$104.5mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2025-01-31$394.8mus-gaap:AssetsCurrent
Total assetsAt period end2025-01-31$2.60bnus-gaap:Assets
Current liabilitiesAt period end2025-01-31$717.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2025-01-31$1.91bnus-gaap:Liabilities
Long-term debtAt period end2025-01-31$877.2mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2025-01-31$10.0mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2025-01-31$685.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000107140-25-000018. Last ingested by Listed: Nov 10, 2026, 22:22 ET. Listed shows no prices and gives no investment advice.